Paper33092083
A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.
Luo Q and 1 other. Cancers (Basel), 2020. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes. Papers, record 33092083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33092083
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31329578 | Aberrant DNA methylation defines isoform usage in cancer, with functional implications. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/31329578 | PubMed |
| 2 | 23724867 | Nivolumab plus ipilimumab in advanced melanoma. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23724867 | PubMed |
| 3 | 23760024 | Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/23760024 | PubMed |
| 4 | 28487507 | Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells. | Sci Rep | 2017 | https://conductscience.org/library/papers/28487507 | PubMed |
| 5 | 17524139 | Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma. | BMC Cancer | 2007 | https://conductscience.org/library/papers/17524139 | PubMed |
| 6 | 31901979 | Genome-wide somatic copy number alteration analysis and database construction for cervical cancer. | Mol Genet Genomics | 2020 | https://conductscience.org/library/papers/31901979 | PubMed |
| 7 | 31349879 | Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31349879 | PubMed |
| 8 | 11325821 | Accelerated age-related CpG island methylation in ulcerative colitis. | Cancer Res | 2001 | https://conductscience.org/library/papers/11325821 | PubMed |
| 9 | 31443960 | European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. | Eur Urol | 2019 | https://conductscience.org/library/papers/31443960 | PubMed |
| 10 | 25584002 | Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25584002 | PubMed |
| 11 | 26263854 | Chronic inflammation in urothelial bladder cancer. | Virchows Arch | 2015 | https://conductscience.org/library/papers/26263854 | PubMed |
| 12 | 11016622 | Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. | Cancer Res | 2000 | https://conductscience.org/library/papers/11016622 | PubMed |
| 13 | 22210181 | Inflammation and immune surveillance in cancer. | Semin Cancer Biol | 2012 | https://conductscience.org/library/papers/22210181 | PubMed |
| 14 | 29107330 | Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. | Cell | 2017 | https://conductscience.org/library/papers/29107330 | PubMed |
| 15 | 27068943 | Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells. | Biochem Soc Trans | 2016 | https://conductscience.org/library/papers/27068943 | PubMed |
| 16 | 30594216 | Classification of triple-negative breast cancers based on Immunogenomic profiling. | J Exp Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30594216 | PubMed |
| 17 | 20021206 | Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development. | Future Oncol | 2010 | https://conductscience.org/library/papers/20021206 | PubMed |
| 18 | 28282548 | Attenuated in vitro effects of IFN-α, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients. | Cytokine | 2017 | https://conductscience.org/library/papers/28282548 | PubMed |
| 19 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 20 | 26952546 | Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. | Lancet | 2016 | https://conductscience.org/library/papers/26952546 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792838 | Molecular Classifications and Candidate Biomarkers for Personalizing BCG Therapy in Non-Muscle-Invasive Bladder Cancer. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792838 | PubMed |
| 40918525 | Epigenetic regulation of bladder cancer in the context of aging. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40918525 | PubMed |
| 40890473 | Fatty acid-binding proteins as potential biomarkers for human cancer prognosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40890473 | PubMed |
| 40693457 | Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder Cancer. | Cancer Med | 2025 | https://conductscience.org/library/papers/40693457 | PubMed |
| 39554534 | Construction and validation of transcription‑factor‑based prognostic signature for TACE non‑response and characterization of tumor microenvironment infiltration in hepatocellular carcinoma. | Oncol Lett | 2025 | https://conductscience.org/library/papers/39554534 | PubMed |
| 38639057 | VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification. | Biosci Rep | 2024 | https://conductscience.org/library/papers/38639057 | PubMed |
| 38281298 | Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38281298 | PubMed |
| 37986009 | Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer. | Eur J Med Res | 2023 | https://conductscience.org/library/papers/37986009 | PubMed |
| 37704682 | FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis. | Sci Rep | 2023 | https://conductscience.org/library/papers/37704682 | PubMed |
| 37453971 | Improved prediction of prognosis and therapy response for lung adenocarcinoma after identification of DNA-directed RNA polymerase-associated lncRNAs. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37453971 | PubMed |
| 37400791 | Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37400791 | PubMed |
| 37224123 | Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer. | PLoS One | 2023 | https://conductscience.org/library/papers/37224123 | PubMed |
| 36440228 | Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36440228 | PubMed |
| 36275774 | A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses. | Front Immunol | 2022 | https://conductscience.org/library/papers/36275774 | PubMed |
| 36211333 | Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA. | Front Immunol | 2022 | https://conductscience.org/library/papers/36211333 | PubMed |
| 35978819 | Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35978819 | PubMed |
| 35858908 | Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus. | BMC Med Genomics | 2022 | https://conductscience.org/library/papers/35858908 | PubMed |
| 35840985 | Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma. | World J Surg Oncol | 2022 | https://conductscience.org/library/papers/35840985 | PubMed |
| 35669882 | Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma. | Front Neurol | 2022 | https://conductscience.org/library/papers/35669882 | PubMed |
| 35592250 | OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35592250 | PubMed |
Genes51
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33092083
GET https://conductscience.org/api/papers/v1/33092083/references?page=2